Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum proteomic changes in normal adult subjects
BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
2) Cellular Growth in Human Myotubes In human cell models 4 , IGF-1 directly drives hypertrophy markers (greater nuclei per myotube, higher fusion index, elevated contractile protein content), reinforcing its role in the cellular foundation of strength and size gains
Interestingly, dietary glycine supplementation selectively increased GSH concentrations in the liver and proximal intestine at both life stages (Table 2)